SecBot SecBot
SECBOTREPLAY Home › Report › KMDA

KMDA · Kamada reported record-high Q2 and H1 2026 results with double-digit…

KAMADA LTD · 6-K filed Aug 12, 2026 at 07:05 ET

At the news

BULLISHIMPACT 6/10

6-K filed Aug 12, 2026 at 07:05 ET

Kamada reported record-high Q2 and H1 2026 results with double-digit revenue and profit growth, driven by strong demand for KEDRAB, VARIZIG, and HEPAGAM. The company affirmed its 2026 annual guidance of $200-205M revenue and $50-53M adjusted EBITDA. A new $50M three-year plasma supply agreement was secured, and the company announced the planned transition of its CFO, Chaime Orlev, effective end of 2026. The strong operational performance is partially offset by a slight gross margin decline and the CFO departure introduces a leadership transition risk.

  • Record-high H1 2026 revenues of $100.2M, up 13% YoY
  • Record-high H1 2026 adjusted EBITDA of $25.7M (26% margin), up 14% YoY
  • Q2 2026 revenues of $54.9M, up 23% YoY; Q2 net income of $9.3M, up 26% YoY
  • Affirmed 2026 annual guidance: $200-205M revenue and $50-53M adjusted EBITDA

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access